Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(2)2021 Jan 18.
Article in English | MEDLINE | ID: mdl-33477687

ABSTRACT

Parasympathetic signalling via muscarinic acetylcholine receptors (mAChRs) regulates gastrointestinal smooth muscle function. In most instances, the mAChR population in smooth muscle consists mainly of M2 and M3 subtypes in a roughly 80% to 20% mixture. Stimulation of these mAChRs triggers a complex array of biochemical and electrical events in the cell via associated G proteins, leading to smooth muscle contraction and facilitating gastrointestinal motility. Major signalling events induced by mAChRs include adenylyl cyclase inhibition, phosphoinositide hydrolysis, intracellular Ca2+ mobilisation, myofilament Ca2+ sensitisation, generation of non-selective cationic and chloride currents, K+ current modulation, inhibition or potentiation of voltage-dependent Ca2+ currents and membrane depolarisation. A lack of ligands with a high degree of receptor subtype selectivity and the frequent contribution of multiple receptor subtypes to responses in the same cell type have hampered studies on the signal transduction mechanisms and functions of individual mAChR subtypes. Therefore, novel strategies such as genetic manipulation are required to elucidate both the contributions of specific AChR subtypes to smooth muscle function and the underlying molecular mechanisms. In this article, we review recent studies on muscarinic function in gastrointestinal smooth muscle using mAChR subtype-knockout mice.


Subject(s)
Gastrointestinal Tract/metabolism , Muscle, Smooth/metabolism , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M3/genetics , Animals , GTP-Binding Proteins/genetics , Gastrointestinal Tract/growth & development , Gastrointestinal Tract/pathology , Mice, Knockout/genetics , Muscle Contraction/genetics , Muscle, Smooth/growth & development , Signal Transduction/genetics
2.
Am J Physiol Cell Physiol ; 318(3): C514-C523, 2020 03 01.
Article in English | MEDLINE | ID: mdl-31875697

ABSTRACT

In mouse ileal myocytes, muscarinic receptor-mediated cationic current (mIcat) occurs mainly through synergism of M2 and M3 subtypes involving Gi/o-type GTP-binding proteins and phospholipase C (PLC). We have further studied the M2/M3 synergistic pathway. Carbachol-induced mIcat was markedly depressed by YM-254890, a Gq/11 protein inhibitor. However, the mIcat was unaffected by heparin, calphostin C, or chelerythrine, suggesting that mIcat activation does not involve signaling molecules downstream of phosphatidylinositol 4,5-bisphosphate (PIP2) breakdown. M2-knockout (KO) mice displayed a reduced mIcat (~10% of wild-type mIcat) because of the lack of M2-Gi/o signaling. The impaired mIcat was insensitive to neuropeptide Y possessing a Gi/o-stimulating activity. M3-KO mice also displayed a reduced mIcat (~6% of wild-type mIcat) because of the lack of M3-Gq/11 signaling, and the mIcat was insensitive to prostaglandin F2α possessing a Gq/11-stimulating activity. These results suggest the importance of Gq/11/PLC-hydrolyzed PIP2 breakdown itself in mIcat activation and also support the idea that the M2/M3 synergistic pathway represents a signaling complex consisting of M2-Gi/o and M3-Gq/11-PLC systems in which both G proteins are special for this pathway but not general in receptor coupling.


Subject(s)
GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Intestinal Mucosa/metabolism , Myocytes, Smooth Muscle/metabolism , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/metabolism , Animals , Cholinergic Agonists/pharmacology , Dose-Response Relationship, Drug , Female , GTP-Binding Protein alpha Subunits, Gi-Go/agonists , Guinea Pigs , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Male , Mice , Mice, 129 Strain , Mice, Knockout , Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/drug effects , Peptides, Cyclic/pharmacology , Receptor, Muscarinic M2/agonists , Receptor, Muscarinic M3/agonists
3.
J Vet Med Sci ; 79(4): 740-744, 2017 Apr 08.
Article in English | MEDLINE | ID: mdl-28302929

ABSTRACT

Isolated rat thoracic aortic strips undergoing noradrenaline-induced contraction were treated with an adult heartworm (HW) crude extract and then examined for isometric changes in tension. HW extract caused relaxation of endothelium-intact strips, but not endothelium-denuded strips. This effect was inhibited by treatment with NG-nitro-L-arginine methyl ester hydrochloride (L-NAME) and could be reversed by additional treatment with L-arginine. However, HW extract at a high concentration caused slight relaxation of endothelium-denuded strips, and relaxation persisted after L-NAME treatment in endothelium intact-strips. These data suggested that the relaxation induced by HW extract was mainly endothelium-dependent, nitric oxide-mediated, but in part, also endothelium-independent. In addition, a bioassay using isolated rat thoracic aortas may be a useful tool for investigating vasoactive substances in the HW extract.


Subject(s)
Aorta, Thoracic/drug effects , Dirofilaria immitis/chemistry , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , Tissue Extracts/pharmacology , Animals , Dogs , Endothelium, Vascular/drug effects , Female , Male , Rats , Rats, Wistar , Tissue Culture Techniques
4.
J Vet Med Sci ; 78(2): 203-11, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26498720

ABSTRACT

In order to investigate the effects of SKF96365 (SKF), which is a non-selective cationic channel blocker, on K(+) channel currents, we recorded currents through ATP sensitive K(+) (IKATP), voltage-gated K(+) (IKv) and Ca(2+) activated K(+) channels (IBK) in the absence and presence of SKF in single small intestinal myocytes of mice with patch-clamp techniques. SKF (10 µM) reversibly abolished IKATP that was induced by cromakalim (10 µM), which is a selective ATP sensitive K(+) channel opener. These inhibitory effects were induced in a concentration-dependent and voltage-independent manner. The 50% inhibitory concentration (IC50) was 0.85 µM, which was obviously lower than that reported for the muscarinic cationic current. In addition, SKF (1 µM ≈ the IC50 value in IKATP suppression) reversibly inhibited the IKv that was induced by repetitive depolarizing pulses from -80 to 20 mV. However, the extent of the inhibitory effects was only ~30%. In contrast, SKF (1 µM) had no significant effects on spontaneous transient IBK and caffeine-induced IBK. These results indicated that SKF inhibited ATP sensitive K(+) channels and voltage-gated K(+) channels, with the ATP sensitive K(+) channels being more sensitive than the voltage-gated K(+) channels. These inhibitory effects on K(+) channels should be considered when SKF is used as a cationic channel blocker.


Subject(s)
Calcium Channel Blockers/pharmacology , Imidazoles/pharmacology , Intestine, Small/drug effects , Myocytes, Smooth Muscle/drug effects , Potassium Channel Blockers/pharmacology , Potassium Channels/metabolism , Animals , Female , In Vitro Techniques , Intestine, Small/cytology , Male , Mice , TRPC Cation Channels/metabolism
5.
Naunyn Schmiedebergs Arch Pharmacol ; 387(4): 377-88, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24322587

ABSTRACT

To elucidate the roles played by the interstitial cells of Cajal in the myenteric layer (ICC-MY) in cholinergic neuromuscular transmission, we recorded mechanical and electrical activities in response to electrical field stimulation (EFS) of the ileal longitudinal muscle strips from WBB6F1-W/W(V) (W/W(V)) mutant mice, that lacked ICC-MY and compared with those in WBB6F1-+/+ (+/+) control mice. In +/+ muscle strips, EFS induced phasic contractions, which were abolished or strongly attenuated by atropine or tetrodotoxin. In W/W(V) preparations, EFS induced similar phasic contractions, but the cholinergic component was smaller than that in +/+ strips. This was despite of the fact that the contractions because of exogenous applications of carbachol and high K(+) solution in W/W(V) strips were comparable to or rather greater than those in the +/+ preparations. EFS induced atropine-sensitive excitatory junction potentials (EJPs) in the +/+ longitudinal smooth muscle cells but not in W/W(V) cells. In the presence of eserine, EFS induced atropine-sensitive EJPs in W/W(V) cells. These results suggest that ICC-MY mediate the cholinergic neuromuscular transmission in mouse ileal longitudinal smooth muscles. In addition, the other pathway in which ICC-MY are not involved can operate concomitantly.


Subject(s)
Ileum/physiology , Interstitial Cells of Cajal/physiology , Muscle, Smooth/physiology , Myenteric Plexus/physiology , Adrenergic Agents/pharmacology , Animals , Atropine/pharmacology , Cholinergic Agents/pharmacology , Electric Stimulation , Guanethidine/pharmacology , Ileum/innervation , In Vitro Techniques , Male , Membrane Potentials , Mice , Mice, Mutant Strains , Muscle Contraction , Muscle, Smooth/innervation , NG-Nitroarginine Methyl Ester/pharmacology , Neuromuscular Junction/physiology , Physostigmine/pharmacology , Synaptic Transmission
6.
J Pharmacol Sci ; 121(3): 227-36, 2013.
Article in English | MEDLINE | ID: mdl-23446189

ABSTRACT

Cholinergic nerve-mediated excitatory junction potentials (EJPs) in the longitudinal muscle of mouse ileum were characterized by using M2 or M3 muscarinic receptor-knockout (KO) mice and 1-[ß-[3-(4-methoxyphenyl) propoxy]-4-methoxyphenethyl]-1H-imidazole hydrochloride (SK&F 96365) and pertussis toxin (PTX). EJPs evoked by electrical field stimulation (EFS) in wild-type preparations, initially determined to be cholinergic in origin using tetrodotoxin, atropine, and eserine, were profoundly depressed after SK&F 96365 treatment known to block muscarinic receptor-operated cation channels. A similar depression of the EJPs was also observed by PTX treatment, which is predicted to disrupt M2-mediated pathways linked to cation channel activation. In M2-KO mouse preparations, cholinergic EJPs were evoked by EFS with their relative amplitude of 20%-30% to the wild-type EJP and strongly inhibited by SK&F 96365. No cholinergic EJP was seen in M3-KO as well as M2/M3 double-KO preparations. The results suggest that the wild-type cholinergic EJP is not a simple mixture of M2 and M3 responses, but due to synergistic activation of cation channels by both M2 and M3 receptors in the murine ileal longitudinal muscle.


Subject(s)
Action Potentials , Chloride Channels/metabolism , Cholinergic Neurons/physiology , Ileum/cytology , Muscle, Smooth/cytology , Myocytes, Smooth Muscle/metabolism , Neuromuscular Junction/physiology , Receptor, Muscarinic M2/physiology , Receptor, Muscarinic M3/physiology , Action Potentials/drug effects , Animals , Cells, Cultured , Chloride Channels/physiology , Electric Stimulation , Female , Male , Mice , Mice, Knockout , Pertussis Toxin/pharmacology
7.
Eur J Pharmacol ; 704(1-3): 7-14, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23461847

ABSTRACT

An isolated atrial preparation of the mouse is useful for analyzing the actions of drugs on the myocardium, autonomic neurons and endocardial endothelium. The aim of the present study was to examine the functions of intrinsic neurons of the atrium using a ganglionic stimulant, 1,1-dimethyl-4-phenylpiperazinium (DMPP). DMPP (1-100 µM) caused a negative chronotropic action followed by a positive chronotropic action in spontaneously beating right atria and also caused biphasic inotropic actions consisting of initial inhibition followed by potentiation of electrical field stimulation (EFS)-induced contraction in the left atria. Inotropic actions in the left atria induced by DMPP were characterized using some autonomic drugs and M2 and/or M3 muscarinic receptor knockout (M2R-KO, M3R-KO and M2M3R-KO) mice. Atropine and hexamethonium decreased the initial negative inotropic actions of DMPP. In the atria from pertussis toxin-treated, M2R-KO and M2/M3R-KO mice, the negative inotropic actions were abolished. On the other hand, the following positive inotropic actions were decreased by hexamethonium, atropine and atenolol. In the atria from reserpine-treated mice, positive inotropic actions were also decreased. The positive inotropic action induced by DMPP was almost the same in M2R-KO mice but was reduced in both M3R-KO mice and M2/M3R-KO mice. In conclusion, DMPP caused biphasic inotropic/chronotropic actions in the mouse atrium through activation of intrinsic cholinergic and adrenergic neurons. M2 and M3 muscarinic receptors and ß1-adrenoceptor are thought to be involved in these actions.


Subject(s)
Dimethylphenylpiperazinium Iodide/pharmacology , Ganglionic Stimulants/pharmacology , Heart Atria/drug effects , Receptor, Muscarinic M2/physiology , Receptor, Muscarinic M3/physiology , Receptors, Adrenergic, beta-1/physiology , Adrenergic beta-1 Receptor Antagonists/pharmacology , Animals , Atenolol/pharmacology , Atropine/pharmacology , Cholinesterase Inhibitors/pharmacology , Electric Stimulation , Female , Heart Rate/drug effects , Male , Mice , Mice, Knockout , Muscarinic Antagonists/pharmacology , Myocardial Contraction/drug effects , Physostigmine/pharmacology , Receptor, Muscarinic M2/antagonists & inhibitors , Receptor, Muscarinic M3/antagonists & inhibitors
8.
Eur J Pharmacol ; 670(1): 236-43, 2011 Nov 16.
Article in English | MEDLINE | ID: mdl-21924260

ABSTRACT

Although muscarinic M(2) and M(3) receptors are known to be important for regulation of gastric and small intestinal motility, muscarinic receptor subtypes regulating colonic function remain to be investigated. The aim of this study was to characterize muscarinic receptors involved in regulation of colonic contractility. M(2) and/or M(3) receptor knockout (KO) and wild-type mice were used in in vivo (defecation, colonic propulsion) and in vitro (contraction) experiments. Amount of feces was significantly decreased in M(3)R-KO and M(2)/M(3)R-KO mice but not in M(2)R-KO mice. Ranking of colonic propulsion was wild-type=M(2)R-KO>M(3)R-KO>M(2)/M(3)R-KO. In vitro, the amplitude of migrating motor complexes in M(2)R-KO, M(3)R-KO and M(2)/M(3)R-KO mice was significantly lower than that in wild-type mice. Carbachol caused concentration-dependent contraction of the proximal colon and distal colon from wild-type mice. In M(2)R-KO mice, the concentration-contraction curves shifted to the right and downward. In contrast, carbachol caused non-sustained contraction and relaxation in M(3)R-KO mice depending on its concentration. Carbachol did not cause contraction but instead caused relaxation of colonic strips from M(2)/M(3)R-KO mice. 4-[[[(3-chlorophenyl)amino]carbonyl]oxy]-N,N,N-trimethyl-2-butyn-1-aminium chloride (McN-A-343) caused a non-sustained contraction of colonic strips from wild-type mice, and this contraction was changed to a sustained contraction by tetrodotoxin, pirenzepine and L-nitroarginine methylester (L-NAME). In the colon of M(2)/M(3)R-KO mice, McN-A-343 caused only relaxation, which was decreased by tetrodotoxin, pirenzepine and L-NAME. In conclusion, M(1), M(2) and M(3) receptors regulate colonic motility of the mouse. M(2) and M(3) receptors mediate cholinergic contraction, but M(1) receptors on inhibitory nitrergic nerves counteract muscarinic contraction.


Subject(s)
Colon/drug effects , Colon/physiology , Gastrointestinal Motility , Receptors, Muscarinic/deficiency , Receptors, Muscarinic/metabolism , (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/pharmacology , Animals , Biomechanical Phenomena , Carbachol/pharmacology , Colon/metabolism , Defecation/drug effects , Female , Gastrointestinal Motility/drug effects , Gene Knockout Techniques , In Vitro Techniques , Male , Mice , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Pirenzepine/pharmacology , Receptors, Muscarinic/genetics
9.
J Vet Med Sci ; 73(4): 453-8, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21139351

ABSTRACT

The present study was designed to explore the inhibitory mechanism by nitric oxide (NO) of the tachykininergic neuro-muscular transmissions in the hamster ileum. In the presence of guanethidine (1 µM), atropine (0.5 µM), nifedipine (0.1 µM) and apamin (100 nM), electrical field stimuli (EFS; 0.5 ms duration, 15 V) evoked non-adrenergic, non-cholinergic excitatory junction potentials (EJPs) in circular smooth muscle cells. The EJPs were markedly inhibited by the tachykinin NK1 receptor antagonists [D-Pro(4), D-Trp(7,9)]-SP(4-11) (3 µM). Both the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 200 µM) and the soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ, 10 µM), did not affect on the resting membrane potentials, but enhanced the tachykininergic EJPs. In the presence of L-NAME (200 µM), exogenously applied NO (10 µM) and the membrane permeable analogue of guanosine 3',5'-cyclic monophosphate (cGMP), 8-bromoguanosine 3',5'-cyclic monophosphate (8-Br-cGMP, 3 mM), significantly inhibited the tachykininergic EJPs. Application of EFS (0.5 msec duration, 15 V) with trains of 20 pulses at 20 Hz increased amount of released substance P (SP). The release of SP was further increased by the treatment of L-NAME or ODQ, but markedly reduced by exogenously applied NO and 8-Br-cGMP. These results suggest that the endogenous NO may inhibit the tachykininergic neuro-muscular transmissions by the decrease of SP release from the tachykininergic neurons, possibly through a guanylate cyclase-cGMP-dependent mechanism in the hamster ileum.


Subject(s)
Cyclic GMP/metabolism , Ileum/metabolism , Neuromuscular Junction/physiology , Nitric Oxide/metabolism , Tachykinins/metabolism , Animals , Cricetinae , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Male , Membrane Potentials , Mesocricetus , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Oxadiazoles/pharmacology , Quinoxalines/pharmacology , Substance P/metabolism
10.
J Vet Med Sci ; 72(4): 443-51, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20009428

ABSTRACT

In the present study, we have characterized muscarinic receptor subtypes that mediate carbachol-induced Ca2+ sensitization of contraction in intestinal smooth muscle, using mutant mice lacking M(2) or M(3) muscarinic receptors or both receptor subtypes. In alpha-toxin-permeabilized muscle strips from wild-type (WT) mice, isometric tension responses to Ca2+ applied cumulatively (pCa 7.0-5.0) were increased when the muscarinic agonist carbachol (100 microM) was added to the medium, as judged from shifts of pCa-tension curves in both 50% effective concentration (EC(50)) and maximum response (E(max)) of pCa-tension curve. In preparations from M(2)-knockout (KO) mice, pCa-tension curves were also shifted by carbachol (100 microM), and the extents of the EC(50) and E(max) changes resembled those observed in preparations from WT mice. In preparations from M(3)-KO or M(2)/M(3)-double KO mice, however, no significant changes in pCa-tension curves were obtained after carbachol application. The G(q/11)-type G-protein inhibitor YM-254890 (1 microM) completely blocked the Ca2+ sensitization of contraction induced by carbachol in M(2)-KO or WT preparations. The results strongly support the idea that the muscarinic activation of Ca2+ sensitization in intestinal smooth muscles is mediated by the M(3) muscarinic receptor coupled to G(q/11)-type G-proteins, without any significant involvement of the other muscarinic receptor subtypes including M(2).


Subject(s)
Calcium/physiology , Ileum/physiology , Intestines/physiology , Mice, Knockout/physiology , Muscle Contraction/physiology , Muscle, Smooth/physiology , Receptor, Muscarinic M2/deficiency , Receptor, Muscarinic M3/deficiency , Receptors, Muscarinic/physiology , Animals , Calcium/pharmacology , Carbachol/pharmacology , Female , Guanosine Triphosphate/pharmacology , Ileum/drug effects , Intestines/drug effects , Male , Mice , Mice, Knockout/genetics , Muscle Contraction/drug effects , Muscle Contraction/genetics , Muscle, Smooth/drug effects , Peptides, Cyclic/pharmacology , Receptor, Muscarinic M2/physiology , Receptor, Muscarinic M3/physiology
11.
J Pharmacol Exp Ther ; 330(2): 487-93, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19429792

ABSTRACT

The potential functional roles of M(3) muscarinic receptors in mouse atria were examined by pharmacological and molecular biological techniques, using wild-type mice, muscarinic M(2) or M(3) receptor single knockout (M(2)KO, M(3)KO), and M(2) and M(3) muscarinic receptor double knockout mice (M(2)/M(3)KO). Real-time quantitative reverse transcriptase-polymerase chain reaction analysis showed that the M(2) receptor mRNA was expressed predominantly in mouse atria but that the M(1), M(3), M(4), and M(5) receptor subtypes were also expressed at low levels. Carbachol (10 nM-30 microM) decreased the spontaneous beating frequency of right atria isolated from wild-type mice. Studies with subtype-preferring antagonists and atria from M(2)KO mice confirmed that this activity is mediated by the M(2) receptor subtype. In left atria from wild-type mice, carbachol decreased the amplitude of electrical field stimulation-evoked contractions (negative inotropic action), but this inhibition was transient and was followed by a gradual increase in contraction amplitude (positive inotropic response). In atria from M(3)KO mice, the transient negative inotropic action of carbachol changed to a sustained negative inotropic action. In contrast, in atria from M(2)KO mice, carbachol showed only positive inotropic activity. In atria from M(2)/M(3) double KO mice, carbachol was devoid of any inotropic activity. These observations, complemented by functional studies with subtype-preferring antagonists, convincingly demonstrate that atrial M(3) muscarinic receptors mediate positive inotropic effects in mouse atria. Physiologically, this activity may serve to dampen the inhibitory effects of M(2) receptor activation on atrial contractility.


Subject(s)
Heart/physiology , Myocardial Contraction/physiology , Receptor, Muscarinic M3/deficiency , Receptor, Muscarinic M3/physiology , Animals , Cholinergic Agonists/pharmacology , Dose-Response Relationship, Drug , Female , Heart/drug effects , Heart Atria/drug effects , Heart Atria/metabolism , Male , Mice , Mice, Knockout , Myocardial Contraction/drug effects , Myocardium/metabolism , Receptor, Muscarinic M3/agonists
12.
Br J Pharmacol ; 158(8): 1874-83, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20050185

ABSTRACT

BACKGROUND AND PURPOSE: Stimulation of muscarinic receptors in intestinal smooth muscle cells results in suppression of voltage-gated Ca2+ channel currents (I(Ca)). However, little is known about which receptor subtype(s) mediate this effect. EXPERIMENTAL APPROACH: The effect of carbachol on I(Ca) was studied in single intestinal myocytes from M2 or M3 muscarinic receptor knockout (KO) and wild-type (WT) mice. KEY RESULTS: In M2KO cells, carbachol (100 microM) induced a sustained I(Ca) suppression as seen in WT cells. However, this suppression was significantly smaller than that seen in WT cells. Carbachol also suppressed I(Ca) in M3KO cells, but with a phasic time course. In M2/M3-double KO cells, carbachol had no effect on I(Ca). The extent of the suppression in WT cells was greater than the sum of the I(Ca) suppressions in M2KO and M3KO cells, indicating that it is not a simple mixture of M2 and M3 receptor responses. The G(i/o) inhibitor, Pertussis toxin, abolished the I(Ca) suppression in M3KO cells, but not in M2KO cells. In contrast, the G(q/11) inhibitor YM-254890 strongly inhibited only the I(Ca) suppression in M2KO cells. Suppression of I(Ca) in WT cells was markedly reduced by either Pertussis toxin or YM-254890. CONCLUSION AND IMPLICATIONS: In intestinal myocytes, M2 receptors mediate a phasic I(Ca) suppression via G(i/o) proteins, while M3 receptors mediate a sustained I(Ca) suppression via G(q/11) proteins. In addition, another pathway that requires both M2/G(i/o) and M3/G(q/11) systems may be operative in inducing a sustained I(Ca) suppression.


Subject(s)
Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/metabolism , Animals , Calcium Channels, L-Type/drug effects , Calcium Channels, L-Type/metabolism , Female , Intestinal Mucosa/metabolism , Intestines/drug effects , Male , Mice , Mice, Knockout , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , Peptides, Cyclic/pharmacology , Pertussis Toxin/pharmacology , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M3/genetics , Time Factors
13.
Environ Toxicol Pharmacol ; 28(1): 70-7, 2009 Jul.
Article in English | MEDLINE | ID: mdl-21783984

ABSTRACT

The effects of tributyltin (TBT) on cytosolic Ca(2+) concentration ([Ca(2+)](c)) and cell viability were investigated in nerve growth factor-differentiated PC12 cells. TBT concentration dependently increased [Ca(2+)](c) with an EC(50) value of 0.07µM. This effect was markedly reduced by removal of the extracellular Ca(2+) or membrane depolarization with a high K(+) medium, but unaffected by thapsigargin causing depletion of intracellular Ca(2+) stores. The L-type voltage-dependent Ca(2+) channel (VDCC) blocker nicardipine blocked the effect of TBT, but the N-type VDCC blocker ω-conotoxin did not. TBT decreased the number of viable cells with an EC(50) value of 0.09µM. The TBT-induced cell death was prevented by nicardipine or by chelating the cytosolic Ca(2+) with BAPTA-AM, but not by ω-conotoxin. The results show that TBT causes an increase in [Ca(2+)](c) via activating L-type VDCCs, and support the idea that the organotin-induced cell death arises through Ca(2+) mobilization via L-type VDCCs.

14.
J Pharmacol Sci ; 108(3): 248-57, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18987432

ABSTRACT

The present study, aiming to elucidate ion channel mechanisms underlying muscarinic receptor-induced depolarization, has characterized membrane currents induced by carbachol in single guinea-pig urinary bladder myocytes. Application of carbachol to cells that were voltage-clamped at -50 mV produced an atropine-sensitive, biphasic inward current consisting of an initial peak followed by a smaller sustained phase. Replacing the extracellular Na+ and intracellular Cl(-) with impermeable tris+ and glutamate(-), respectively, demonstrated that the biphasic current is entirely composed of cation currents. Its initial peak phase was abolished by buffering intracellular Ca2+ to a constant level of 100 nM or depleting intracellular Ca2+ stores, and it was mimicked by the Ca2+ releaser caffeine. Ca2+ entry evoked by voltage steps in the sustained phase induced no noticeable change, indicating that this phase of cation current is insensitive to a rise of [Ca2+]i. These results demonstrate that muscarinic receptor stimulation invokes the openings of two types of cation channel, a Ca2+-activated and a receptor-operated type; the former channels are gated by a rise in [Ca2+]i upon intracellular Ca2+ release, and the latter are gated through other muscarinic receptor-coupled signal transduction mechanisms.


Subject(s)
Carbachol/pharmacology , Ion Channels/drug effects , Muscarinic Agonists/pharmacology , Muscle, Smooth/drug effects , Myocytes, Smooth Muscle/drug effects , Receptors, Muscarinic/drug effects , Urinary Bladder/drug effects , Animals , Calcium/metabolism , Cations , Dose-Response Relationship, Drug , Guinea Pigs , Ion Channel Gating/drug effects , Ion Channels/metabolism , Male , Membrane Potentials , Muscle, Smooth/metabolism , Myocytes, Smooth Muscle/metabolism , Potassium/metabolism , Receptors, Muscarinic/metabolism , Signal Transduction/drug effects , Sodium/metabolism , Time Factors , Urinary Bladder/metabolism
15.
J Physiol Sci ; 58(6): 419-24, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18845060

ABSTRACT

We examined the fail-safe responses against low-dose botulinum intoxication (botulinum neurotoxin serotype A; 0.05 ng/35 g body weight) in electrically activated in vitro phrenic nerve-diaphragm preparations, since sustained ventilation is critical for the prognosis of clinical botulinum intoxication. At 0, 1, 2 and 4 wks after the peritoneal injection of the toxin, both contractility and neurotransmitter release were measured. There was an increase in directly induced twitch force without affecting directly induced tetanus throughout the observation period. Indirectly induced twitch force decreased by 60% at 1 wk, which gradually recovered only during the 4-wk observation period. Spontaneous neurotransmitter release, evaluated as the frequency of miniature end plate potentials, was largely abolished 1 wk after the injection and recovered only slightly during the 4-wk period. The effects on spontaneous release were independent of medium Ca2+ concentration. Evoked release, evaluated as quantal content, was also mostly inhibited at 1 wk, but it recovered to approximately 50% of controls at 4 wks. The recovery of quantal content was more prominent at low medium Ca2+ concentration. These results indicated two functional fail-safe responses that compensate for the acute inhibitory effect of low dose of botulinum toxin on neuromuscular transmission; increased contractility of muscle, and improved efficiency of evoked quantum release. The increased contractility probably reflects remodeling of muscle fiber composition of the diaphragm. The improved efficiency of evoked quantum release probably involves remodeling of voltage-gated Ca2+ channels, intracellular Ca2+ store sites, or transmitter-releasing apparatuses.


Subject(s)
Botulinum Toxins, Type A/pharmacology , Calcium/metabolism , Diaphragm/innervation , Motor Neurons/drug effects , Muscle Contraction/drug effects , Phrenic Nerve/drug effects , Presynaptic Terminals/drug effects , Animals , Botulinum Toxins, Type A/administration & dosage , Electric Stimulation , Female , Injections, Intraperitoneal , Male , Mice , Miniature Postsynaptic Potentials , Motor Neurons/metabolism , Phrenic Nerve/metabolism , Presynaptic Terminals/metabolism , Recovery of Function , Time Factors
16.
Eur J Pharmacol ; 599(1-3): 54-7, 2008 Dec 03.
Article in English | MEDLINE | ID: mdl-18845139

ABSTRACT

Application of 1-oleoyl-2-acetyl-sn-glycerol (OAG), an analogue of diacylglycerol (DAG) formed via M(3) muscarinic receptors, induced inward cationic currents via a protein kinase C-independent mechanism and produced membrane depolarization with increased action potential discharges in mouse intestinal myocytes. Outside-out patches from the myocytes responded to OAG with openings of 115-pS channels characterized by a mean open time (O(tau)) of 0.15 ms. M(3) receptor stimulation is reportedly capable of causing brief openings (O(tau)=0.23 ms) of 120-pS cationic channels in intestinal myocytes, thus the present results strongly support the idea that the M(3)-mediated 120-pS channel opening is brought about via DAG-dependent mechanisms.


Subject(s)
Diglycerides/pharmacology , Ion Channels/drug effects , Myocytes, Smooth Muscle/drug effects , Receptor, Muscarinic M3/metabolism , Action Potentials/drug effects , Animals , Cations/metabolism , Electrophysiology , Female , Intestine, Small/metabolism , Ion Channels/metabolism , Male , Mice , Myocytes, Smooth Muscle/metabolism , Patch-Clamp Techniques , Protein Kinase C/metabolism
17.
Naunyn Schmiedebergs Arch Pharmacol ; 377(4-6): 503-13, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18071676

ABSTRACT

Functional muscarinic acetylcholine receptors present in the mouse uterus were characterized by pharmacological and molecular biological studies using control (DDY and wild-type) mice, muscarinic M2 or M3 single receptor knockout (M2KO, M3KO), and M2 and M3 receptor double knockout mice (M2/M3KO). Carbachol (10 nM-100 microM) increased muscle tonus and phasic contractile activity of uterine strips of control mice in a concentration-dependent manner. The maximum carbachol-induced contractions (Emax) differed between cervical and ovarian regions of the uterus. The stage of the estrous cycle had no significant effect on carbachol concentration-response relationships. Tetrodotoxin did not decrease carbachol-induced contractions, but the muscarinic receptor antagonists (11-[[2-[(diethylaminomethyl)-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b[2,3-b][1,4]benzodiazepin6-one (AF-DX116), N-[2-[2-[(dipropylamino)methyl]-1-piperidinyl]ethyl]-5,6-dihydro-6-oxo-11H-pyrido[2,3-b][1,4] benzodiazepine-11-carboxamide (AF-DX384), 4-diphenylacetoxy-N-methyl-piperidine(4-DAMP), para-fluoro-hexa hydro-sila-diphenidol (p-F-HHSiD), himbacine, methoctramine, pirenzepine, and tropicamide) inhibited carbachol-induced contractions in a competitive fashion. The pKb values for these muscarinic receptor antagonists correlated well with the known pKi values of these antagonists for the M3 muscarinic receptor. In uterine strips isolated from mice treated with pertussis toxin (100 microg/kg, i.p. for 96 h), Emax values for carbachol were significantly decreased, but effective concentration that caused 50% of Emax values (EC50) remained unchanged. In uterine strips treated with 4-DAMP mustard (30 nM) and AF-DX116 (1 microM), followed by subsequent washout of AF-DX116, neither carbachol nor N,N,N,-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium iodide (oxotremorine-M) caused any contractile responses. Both M2 and M3 muscarinic receptor messenger RNAs were detected in the mouse uterus via reverse transcription polymerase chain reaction. Carbachol also caused contraction of uterine strips isolated from M2KO mice, but the concentration-response curve was shifted to the right and downward compared with that for the corresponding wild-type mice. On the other hand, uterine strips isolated from M3KO and M2/M3 double KO mice were virtually insensitive to carbachol. In conclusion, although both M2 and M3 muscarinic receptors were expressed in the mouse uterus, carbachol-induced contractile responses were predominantly mediated by the M3 receptor. Activation of M2 receptors alone did not cause uterine contractions; however, M2 receptor activation enhanced M3 receptor-mediated contractions in the mouse uterus.


Subject(s)
Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Receptor, Muscarinic M2/drug effects , Receptor, Muscarinic M3/drug effects , Animals , Carbachol/administration & dosage , Cholinergic Agonists/administration & dosage , Dose-Response Relationship, Drug , Estrous Cycle , Female , Mice , Mice, Knockout , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/genetics , Receptor, Muscarinic M3/metabolism , Tetrodotoxin/pharmacology , Uterus/drug effects , Uterus/metabolism
18.
Toxicology ; 243(1-2): 155-63, 2008 Jan 14.
Article in English | MEDLINE | ID: mdl-18023957

ABSTRACT

This study was designed to investigate the effects of several pyrethroids on the extracellular level of glutamate and gamma-aminobutyric acid (GABA) in the hippocampus of rats measured using microdialysis following systemic (i.p.) administration. Pyrethroids, allethrin (type I), cyhalothrin (type II) and deltamethrin (type II), were found to have differential effects on glutamatergic and GABAergic neurons in the hippocampus. Allethrin had an interesting dual effect, increasing glutamate release with low doses (10 and 20mg/kg) to about 175-150% and decreasing glutamate release with high dose (60 mg/kg) to about 50% of baseline. Cyhalothrin (10, 20 and 60 mg/kg) inhibited the release of glutamate dose-dependently to about 60-30% of baseline. The extracellular level of GABA was decreased to about 50% of baseline by 10 and 20mg/kg allethrin. The high dose of allethrin (60 mg/kg) and all doses of cyhalothrin (10, 20 and 60 mg/kg) increased the extracellular level of GABA while decreasing the level of glutamate. Deltamethrin dose-dependently increased extracellular glutamate levels to about 190-275% of baseline while decreasing the level of GABA. Local infusion of TTX (1 microM), a Na(+) channel blocker, completely prevented the effect of allethrin (10, 20 and 60 mg/kg), cyhalothrin (20 and 60 mg/kg) and deltamethrin (20mg/kg) on glutamate and GABA release, but only partially blocked the effects of 60 mg/kg deltamethrin. The effect of deltamethrin (60 mg/kg) on glutamate release was completely prevented by local infusion of nimodipine (10 microM), an L-type Ca(2+) channel blocker. Collectively, results from this study suggest that the excitatory glutamatergic neurons in the hippocampus are modulated by inhibitory GABA-releasing interneurons and that other mechanisms, beside sodium channels, may be involved with the neurotoxic action of pyrethroids.


Subject(s)
Glutamic Acid/metabolism , Hippocampus/drug effects , Insecticides/toxicity , Neurons/drug effects , Pyrethrins/toxicity , Synaptic Transmission/drug effects , gamma-Aminobutyric Acid/metabolism , Animals , Extracellular Fluid/metabolism , Hippocampus/metabolism , Male , Microdialysis , Neurons/metabolism , Rats , Rats, Sprague-Dawley , Time Factors
19.
J Physiol ; 582(Pt 1): 41-61, 2007 Jul 01.
Article in English | MEDLINE | ID: mdl-17463038

ABSTRACT

Using mutant mice genetically lacking certain subtypes of muscarinic receptor, we have studied muscarinic signal pathways mediating cationic channel activation in intestinal smooth muscle cells. In cells from M2 subtype-knockout (M2-KO) or M3-KO mice, carbachol (100 microM) evoked a muscarinic cationic current (mI(Cat)) as small as approximately 10% of mI(Cat) in wild-type (WT) cells. No appreciable current was evoked in M2/M3 double-KO cells. All mutant type cells preserved normal G-protein-cationic channel coupling. The M3-KO and WT mI(Cat) each showed a U-shaped current-voltage (I-V) relationship, whereas the M2-KO mI(Cat) displayed a linear I-V relationship. Channel analysis in outside-out patches recognized 70-pS and 120-pS channels as the major muscarinic cationic channels. Active patches of M2-KO cells exhibited both 70-pS and 120-pS channel activity usually together, either of which consisted of brief openings (the respective mean open times O(tau) = 0.55 and 0.23 ms). In contrast, active M3-KO patches showed only 70-pS channel activity, which had three open states (O(tau) = 0.55, 3.1 and 17.4 ms). In WT patches, besides the M2-KO and M3-KO types, another type of channel activity was also observed that consisted of 70-pS channel openings with four open states (O(tau) = 0.62, 2.7, 16.9 and 121.1 ms), and patch current of this channel activity showed a U-shaped I-V curve similar to the WT mI(Cat). The present results demonstrate that intestinal myocytes are endowed with three distinct muscarinic pathways mediating cationic channel activation and that the M2/M3 pathway targeting 70-pS channels, serves as the major contributor to mI(Cat) generation. The delineation of this pathway is consistent with the formation of a functional unit by the M2-Go protein and the M3-PLC systems predicted to control cationic channels.


Subject(s)
Ileum/metabolism , Ion Channels/metabolism , Jejunum/metabolism , Muscle, Smooth/metabolism , Myocytes, Smooth Muscle/metabolism , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/metabolism , Signal Transduction , Animals , Carbachol/pharmacology , Cations/metabolism , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Ileum/cytology , Ileum/drug effects , In Vitro Techniques , Ion Channel Gating , Ion Channels/chemistry , Jejunum/cytology , Jejunum/drug effects , Kinetics , Membrane Potentials , Mice , Mice, Knockout , Models, Molecular , Muscarinic Agonists/pharmacology , Muscle, Smooth/cytology , Muscle, Smooth/drug effects , Myocytes, Smooth Muscle/drug effects , Patch-Clamp Techniques , Protein Conformation , Receptor, Muscarinic M2/agonists , Receptor, Muscarinic M2/deficiency , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M3/agonists , Receptor, Muscarinic M3/deficiency , Receptor, Muscarinic M3/genetics , Type C Phospholipases/metabolism
20.
Eur J Pharmacol ; 554(2-3): 212-22, 2007 Jan 12.
Article in English | MEDLINE | ID: mdl-17113073

ABSTRACT

Functional roles of muscarinic acetylcholine receptors in the regulation of mouse stomach motility were examined using mice genetically lacking muscarinic M(2) receptor and/or M(3) receptor and their corresponding wild-type (WT) mice. Single application of carbachol (1 nM-30 microM) produced concentration-dependent contraction in antral and fundus strips from muscarinic M(2) receptor knockout (M(2)R-KO) and M(3) receptor knockout (M(3)R-KO) mice but not in those from M(2) and M(3) receptors double knockout (M(2)/M(3)R-KO) mice. A comparison of the concentration-response curves with those for WT mice showed a significant decrease in the negative logarithm of EC(50) (pEC(50)) value (M(2)R-KO) or amplitude of maximum contraction (M(3)R-KO) in the muscarinic receptor-deficient mice. The tonic phase of carbachol-induced contraction was decreased in gastric strips from M(3)R-KO mice. Antagonistic affinity for 4-diphenylacetoxy-N-methyl-piperidine (4-DAMP) or 11-([2-[(diethylamino)methyl]-1-piperdinyl]acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6-one (AF-DX116) indicated that the contractile responses in M(2)R-KO and M(3)R-KO mice were mediated by muscarinic M(3) and M(2) receptors, respectively. Electrical field stimulation (EFS, 0.5-32 Hz) elicited frequency-dependent contraction in physostigmine- and N(omega)-nitro-L-arginine methylester (l-NAME)-treated fundic and antral strips from M(2)R-KO and M(3)R-KO mice, but the cholinergic contractile components decreased significantly compared with those in WT mice. In gastric strips from M(2)/M(3)R-KO mice, cholinergic contractions elicited by EFS were not observed but atropine-resistant contractions were more conspicuous than those in gastric strips from WT mice. Gastric emptying in WT mice and that in M(2)/M(3)R-KO mice were comparable, suggesting that motor function of the stomach in the KO mice did not differ from that in the WT mice. The results indicate that both muscarinic M(2) and M(3) receptors but not other subtypes mediate carbachol- or EFS-induced contraction in the mouse stomach but that the contribution of each receptor to concentration-response relationships is distinguishable. Although there was impairment of nerve-mediated cholinergic responses in the stomach of KO mice, gastric emptying in KO mice was the same as that in WT mice probably due to the compensatory enhancement of the non-cholinergic contraction pathway.


Subject(s)
Muscle Contraction/physiology , Muscle, Smooth/physiology , Receptor, Muscarinic M2/physiology , Receptor, Muscarinic M3/physiology , Stomach/physiology , Animals , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , Enzyme Inhibitors/pharmacology , Female , Gastric Emptying/drug effects , Gastric Emptying/physiology , Gastric Fundus/drug effects , Gastric Fundus/physiology , Genotype , In Vitro Techniques , Male , Mice , Mice, Inbred Strains , Mice, Knockout , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Muscle, Smooth/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Physostigmine/pharmacology , Piperidines/pharmacology , Pirenzepine/analogs & derivatives , Pirenzepine/pharmacology , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M3/genetics , Stomach/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...